ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
4534	Centers for Disease Control and Prevention	Html	en	HIV/AIDS and the Flu	People with HIV/AIDS are at increased risk of from serious complications from flu - CDC	influenza infection 0.501945 influenza antiviral agents 0.63814 influenza antiviral drugs 0.667501 influenza-related complications 0.515811 HIV-infected persons 0.42386 influenza symptoms 0.516587 ) site. 0.403636 HIV attacks cells 0.495183 antiviral chemoprophylaxis agents 0.423702 example people 0.271816 influenza vaccine 0.772204 seasonal influenza 0.451262 Current CDC guidance 0.339385 certain cancers 0.257269 AIDS 0.324424 lung-related hospitalizations 0.258934 flu antiviral drugs 0.607227 severe paralyzing illness 0.35283 active antiretroviral therapy 0.382402 life-threatening allergic reaction 0.355979 adverse drug reactions 0.339672 inactivated influenza vaccine 0.708354 live influenza virus 0.579897 high risk 0.524724 human immunodeficiency virus 0.401732	antiviral medications 0.468161 advanced HIV disease 0.466354 influenza 0.945315 milder egg allergies 0.357093 United States 0.261501 flu vaccine 0.692463 flu complications 0.533244 certain people 0.294613 flu shots 0.448588 immune response 0.399622 immunodeficiency syndrome 0.269297 health care workers 0.515621 influenza season 0.515875 greater chance 0.360241 certain HIV-infected people 0.492132 people 0.703661 influenza vaccination 0.628795 flu 0.81856 local public health 0.337326 nasal spray vaccine 0.430377 flu shot 0.452227 HIV 0.586511 influenza viruses 0.510023 poor immune response 0.373602	CLICK HERE
4929	Centers for Disease Control and Prevention	Html	en	2009 H1N1: Overview of a Pandemic - Background on Influenza	null	coronary artery disease 0.573238 contagious respiratory illness 0.604145 United States 0.637286 flu cough 0.641159 new H1N1 virus 0.631679 mild respiratory illness 0.566121 flu virus 0.836471 flu complications 0.617272 sickle cell disease 0.57484 Highest complication rates 0.558284 Highest illness rates 0.578925 small particle droplet 0.570799 Influenza type 0.717407 congenital heart disease 0.575234 congestive heart failure 0.550873 Flu seasons 0.633486 Section 508-accessible version 0.581801 Body Mass Index 0.551268 influenza vaccine 0.749358 metabolic disorders 0.549293 large droplet transmission 0.568353 Seasonal Flu website 0.747269 influenza A subtype 0.723709	seasonal influenza 0.817986 Influenza results 0.740374 weakened immune systems 0.571614 (contact transmission) 0.556828 flu viruses 0.827007 people 0.60626 severely ill persons 0.559384 Chronic lung disease 0.569708 English language content 0.583207 stand-alone Web document 0.578961 influenza viruses 0.983287 way influenza viruses 0.890383 substantial economic impact 0.558006 et al 0.549413 influenza b viruses 0.916994 flu season 0.623307 particular flu virus 0.757355 illness onset 0.571357 influenza a viruses 0.892422 newer virus strains 0.638772 Human influenza 0.718386 obstructive pulmonary disease 0.573475	CLICK HERE
6954	Centers for Disease Control and Prevention	Html	en	CDC - Preventing Chronic Disease: Volume 9, 2012:11_0142	In Ethiopia, lack of reliable data on causes of death prevents full understanding of the double mortality burden of communicable and noncommunicable diseases. Our objective was to help bridge this research gap by analyzing surveillance data on causes of death in Addis Ababa.	epidemiological transition 0.450659 verbal autopsy interviews 0.378409 injuries 0.397193 premature death rate 0.37135 female deaths 0.468894 major causes 0.37466 World Bank 0.382656 standardized verbal autopsy 0.377378 deaths 0.79482 group 0.432318 burial surveillance records 0.369716 adult death rates 0.382466 World Health Organization 0.412216 digestive tract diseases 0.582305 Addis Ababa 0.988385 verbal autopsies 0.530933 verbal autopsy questionnaire 0.412811 Mortality Surveillance Program 0.455029 overall death rates 0.38049 Addis Ababa population 0.49409 death rates 0.426895 age-specific death rate 0.381623 Addis Ababa residents 0.532789 Ethiopia 0.368765 study 0.453291	death 0.62983 age group 0.418825 adults 0.421231 Addis Ababa Labour 0.470651 communicable diseases 0.682389 Addis Ababa University 0.472553 death rate 0.395994 typical mortality burden 0.371307 Premature deaths 0.44455 burial surveillance 0.544258 verbal autopsy 0.492162 causes 0.508537 premature death increases 0.373169 double mortality burden 0.591632 Addis Ababa Mortality 0.543086 Ababa Mortality Surveillance 0.512489 noncommunicable diseases 0.914211 CVD deaths 0.417503 Addis Ababa cemeteries 0.489058 adult deaths 0.442934 deceased Addis Ababa 0.495084 infant deaths 0.41306 malignant neoplasm 0.413019 proportional death rates 0.3817	CLICK HERE
8644	Centers for Disease Control and Prevention	Html	en	PanFlu Storybook - I Survived, Clella B. Gregory	I Survived, The staggering statistics associated with pandemics sometimes makes it difficult to remember that each number represents a single, human life. In this section, survivors share their intimate recollections of either their own illness or that of a loved one. All these storytellers are 90-plus years of age and they have carried with them for a lifetime their memories of the 1918 flu pandemic.	Clella B. Gregory 0.925989 pandemic flu 0.686613 Olpha Otis 0.683709 heat 0.359104 siblings 0.388888 brothers 0.366499 father 0.362635 Claude 0.37715 church services 0.631551 crowds 0.38474 mother 0.359643 Nora Brantley 0.755641 children 0.363917 Storyteller 0.384558 livestock 0.358441 wood 0.359159 drinking water 0.635248 Ruby 0.364135	parents Eli 0.758044 baby Helen 0.668477 illness 0.362977 Dad 0.48326 cows 0.369928 community 0.362532 Herb 0.372529 Ina Pearl 0.682528 sick neighbors 0.659724 Floy 0.366268 schools 0.35925 doctors 0.35772 Blackford 0.532587 coal 0.364372 Bert 0.37886 family 0.35792 brother Genie 0.681325 age 0.558228	CLICK HERE
8819	Centers for Disease Control and Prevention	Html	en	Building Laboratory Capacity to Support the Global RotavirusSurveillance Network	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	rotavirus surveillance activities 0.782734 rotavirus tests 0.658443 global laboratory network 0.596598 rotavirus diarrhea 0.675426 rotavirus genotypes 0.736913 regional laboratory network 0.606595 rotavirus laboratory 0.835048 standard genotyping data 0.569975 national laboratories 0.778772 Global Rotavirus Surveillance 0.803179 Global Reference Laboratory 0.707976 quality laboratory data 0.62278 data quality assurance 0.568191 national immunization programs 0.704935 laboratory surveillance networks 0.655474 rotavirus diagnosis 0.649492 World Health Organization 0.667767 rotavirus detection 0.804904 oral rotavirus vaccines 0.756555 rotavirus specimens 0.675078 regional laboratory surveillance 0.635215 global laboratory networks 0.574136 laboratory performance monitoring 0.557744 Regional Office 0.604843 individual genotypes 0.601268	reported absolute numbers 0.639222 global rotavirus detection 0.72237 rotavirus strain types 0.766723 Global Rotavirus Laboratory 0.796061 disease burden data 0.636509 sentinel hospital laboratories 0.911335 Rotavirus regional reference 0.759627 severe rotavirus disease 0.697784 timely rotavirus disease 0.700958 national reference laboratories 0.58137 rotavirus vaccine introduction 0.968688 proficiency testing 0.588036 rotavirus testing 0.684797 laboratory network capacities 0.559435 laboratory methods 0.587222 global surveillance network 0.59268 regional reference laboratories 0.768979 rotavirus vaccine licensure 0.776963 data collection 0.590352 clinical trial data 0.557095 regional rotavirus laboratory 0.833563 quality surveillance data 0.605587 rotavirus vaccination 0.694192 prevalent genotypes 0.555328	CLICK HERE
12514	Centers for Disease Control and Prevention	Video	en	CAUTI: Definition Changes for 2015	This Hot Topic presentation focuses on changes to Chapter Two of the National Healthcare Safety Network Patient Safety Manual for 2015. This protocol is used for reporting to the National Healthcare Safety Network for the CMS Hospital Inpatient Quality Reporting Program. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://streaming.cdc.gov/vod.php?id=a8f5c20959328d86a0461bb681695c8120141120105015687	CAUTI 0.571892	Definition Changes 0.985319	CLICK HERE
13071	Centers for Disease Control and Prevention	Video	null	Screening for Colorectal Cancer: Optimizing Quality (CME). Endoscopist Version Part 2	Part 2 of the Endoscopist Version CME focuses on colonoscopy and includes pre-procedure considerations for ensuring that colonoscopy is appropriate, ways to achieve good bowel preparation, the elements required for complete reporting, effective communication with referring providers and patients, and monitoring quality indicators to improve performance. It is the second of two parts of a continuing education activity that provides guidance and tools for clinicians on the optimal ways to implement screening for colorectal cancer to help ensure that patients receive maximum benefit. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://www.cdc.gov/cancer/videos/colorectal/quality/Endoscopist2/CRC_Screening_Optimizing_Quality_Endoscopist2_256k.mp4			CLICK HERE
13201	Centers for Disease Control and Prevention	Html	en	Announcement: CDC-Sponsored Continuing Education Courses onScreening for Colorectal Cancer	Colorectal cancer is the second leading cancer killer in the United States. Screening for colorectal cancer saves lives, but problems with its implementation in clinical practice can reduce screening's effectiveness.	CDC-sponsored continuing education 0.648923 endorsement 0.399693 Human Services 0.637746 leaders 0.329283 research 0.329228 U.S. Department 0.632227 MMWR HTML versions 0.622939 primary care providers 0.642609 education credits 0.481567 physicians 0.328979 electronic PDF version 0.602772 colorectal cancer screening 0.798357 health professionals 0.490799 courses 0.357828 colorectal cancer 0.980273 lives 0.332273 Contact GPO 0.514566 maximum benefit 0.480483 patients 0.33008 commercial sources 0.477806 primary care clinicians 0.683504 current prices 0.467503 original paper copy 0.599882 problems 0.332244	best ways 0.488882 nationally recognized experts 0.631776 United States 0.503722 U.S. Government Printing 0.600959 clinical practice 0.501541 Superintendent 0.334044 tools 0.330219 MMWR readers 0.484208 character translation 0.46652 MMWR paper copy 0.612345 course 0.3298 format errors 0.473712 effectiveness 0.329715 colonoscopy procedures 0.501572 implementation 0.332215 typeset documents 0.480424 public health programs 0.646845 trade names 0.477975 official text 0.463841 cancer killer 0.518773 non-CDC sites 0.475306 http://www.cdc.gov/cancer/colorectal/quality 0.329565 electronic conversions 0.466122 printable versions 0.464393	CLICK HERE
13806	Centers for Disease Control and Prevention	Html	en	Human Papillomavirus Vaccination Coverage Among FemaleAdolescents in Managed Care Plans - United States, 2013	Judy Ng, PhD1,2; Faye Ye, MS1; Lindsey Roth, MPP1; Katherine Sobel1; Sepheen Byron, MHS1; Mary Barton, MD1; Megan Lindley, MPH3; Shannon Stokley, MPH3.	commercial plans 0.520603 hpv vaccine 0.715324 higher performing plans 0.361801 health plans 0.518531 adolescent plan members 0.448189 Medicaid health plans 0.440442 health maintenance organizations 0.360232 HEDIS results 0.383523 Medicaid plan 0.36152 highest-performing health plans 0.373019 HPV vaccination coverage 0.763627 vaccination coverage levels 0.447327 Medicaid 0.452506 HEDIS HPV vaccination 0.625779 vaccination measure data 0.425479 clear HPV vaccination 0.492835 Female Adolescents measure 0.411187 Medicaid plans 0.435088 female adolescent members 0.401774 percentage point difference 0.392844 Low HPV vaccination 0.487326 HPV vaccination series 0.552254 routine HPV vaccine 0.446947 HPV infections 0.486932	commercial versus Medicaid 0.377544 HHS regions 0.370266 highest-performing commercial plans 0.375354 HEDIS HPV Vaccine 0.555399 HPV vaccination 0.923341 United States 0.466348 higher vaccination coverage 0.401721 median HPV vaccination 0.521438 U.S. health plans 0.382159 low vaccination coverage 0.402121 3-dose HPV coverage 0.461717 HPV vaccination rates 0.499193 quadrivalent HPV vaccine 0.45877 female adolescent plan 0.449266 female adolescents 0.519683 HPV measure 0.474897 Medicaid PPOs report 0.383762 HPV vaccination measure 0.671552 persistent HPV infection 0.473531 3-dose HPV vaccination 0.556269 Adolescents performance measure 0.412032 different plan categories 0.359725 HEDIS measures 0.380487 13th birthday 0.370664	CLICK HERE
14114	Centers for Disease Control and Prevention	Html	en	Protect Yourself & Your Family Against the Flu | CDC Features	Each flu season, flu causes millions of illnesses, hundreds of thousands of hospitalizations and thousands or sometimes tens of thousands of deaths. Vaccination can reduce flu illnesses, doctors' visits, and missed work and school due to flu, as well as prevent flu-related hospitalizations.	coronary artery disease 0.40019 high risk groups 0.409417 influenza antiviral drugs 0.408269 different flu viruses 0.754764 sickle cell disease 0.400767 flu vaccines 0.661404 congestive heart failure 0.39397 Healthy people 0.381488 Body Mass Index 0.398544 metabolic disorders 0.390248 greater risk 0.48442 important steps 0.366477 risk suspect flu 0.666126 sick people 0.379734 flu illness 0.680013 flu antiviral drugs 0.663008 rare exceptions 0.365435 Chronic lung disease 0.399711 vaccine effectiveness 0.380161 his/her first dose 0.36581 high risk 0.504643 Flu activity 0.658032 flu illnesses 0.655443 obstructive pulmonary disease 0.400393	flu symptoms 0.662298 United States 0.418501 alcohol-based hand rub 0.406721 chronic health conditions 0.400145 flu-related deaths 0.375502 flu vaccine 0.765501 flu complications 0.690516 flu-related hospitalizations 0.450763 Flu vaccination 0.660158 everyday preventative actions 0.400845 vaccine viruses 0.393565 flu-related complications 0.386389 congenital heart disease 0.399771 prevent flu-related hospitalizations 0.450404 health care 0.409812 spinal cord injury 0.391934 long-term care facilities 0.396429 flu viruses 0.755434 people 0.466889 flu 0.912373 influenza complications 0.365679 CDC Flu Website 0.640804 best possible protection 0.407869 long-term aspirin therapy 0.396491	CLICK HERE